EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length

Benjamin J Behers iD, Brett M Behers, Christoph A Stephenson-Moe, Ian A Vargas, Zhuo Meng, Anthony J Thompson, Julian Melchor, Caroline N Wojtas, Manuel A Rosario, Joel F Baker, Alexander C Deevers, Roxann W Mouratidis und 1 weitere

Nutrients · 24.10.2024 · 16 (21) · 3617

DOI: 10.3390/nu16213617 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Nutrients, online erschienen am 24.10.2024. Verfasst von Benjamin J Behers und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL 32304, USA. Hauptthemen laut MEDLINE: Blood Pressure, Dietary Supplements, Magnesium. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Studies have shown that consistent reductions of 2 mm Hg in systolic blood pressure (SBP) for the general normotensive population can result in significant decreases in mortality from heart disease and stroke. The purpose of this meta-analysis was to determine the optimal dose and duration of treatment for magnesium and potassium supplementation, having previously discovered that both reduce SBP by −2.79 and −2.10 mm Hg, respectively.

Methods

Placebo-controlled, randomized clinical trials examining the effects of magnesium and potassium supplementation on SBP were identified. Pairwise meta-analyses with subgroups for dosage and treatment duration were run.

Results

Magnesium at dosages of ≤360 mg/day and durations greater than 3 months reduced SBP by −3.03 and −4.31 mm Hg, respectively. Potassium at dosages of ≤60 mmol/day and durations greater than 1 month reduced SBP by −2.34 and −2.80 mm Hg, respectively.

Conclusions

Both supplements demonstrated greater reductions in SBP for the general population at lower dosages and longer treatment durations. Future studies are needed to validate these findings and provide tailored recommendations. These studies could investigate varying dosages over long-term follow-up to provide robust data on optimal dosages and treatment durations, as our findings were limited due to reliance on previously published trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PressureDietary SupplementsMagnesiumHumansDose-Response Relationship, DrugHypertensionPotassiumRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

cardiovascular diseaseheart diseasemagnesiumnutraceuticalspotassiumstroke

Substanzen

MagnesiumPotassium

Autor:innen und Institutionen

  • Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL 32304, USA.
  • Florida State University Internal Medicine Residency at Sarasota Memorial Hospital, Sarasota, FL 34239, USA.
  • Department of Clinical Research, University of South Florida College of Medicine, Tampa, FL 33602, USA.
  • Department of Statistics, Florida State University, Tallahassee, FL 32306, USA.
  • Department of Clinical Research, University of Florida, Gainesville, FL 32603, USA.

ORCID-Profile: Benjamin J Behers

Zitieren

APA

Behers, B. J., Behers, B. M., Stephenson-Moe, C. A., Vargas, I. A., Meng, Z., Thompson, A. J., Melchor, J., Wojtas, C. N., Rosario, M. A., Baker, J. F., Deevers, A. C., Mouratidis, R. W., & Sweeney, M. J. (2024). Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients, 16(21), 3617. https://doi.org/10.3390/nu16213617

Vancouver

Behers BJ, Behers BM, Stephenson-Moe CA, Vargas IA, Meng Z, Thompson AJ, et al. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length. Nutrients. 2024;16(21):3617. doi:10.3390/nu16213617

BibTeX
@article{Behers2024,
  author = {Behers, Benjamin J and Behers, Brett M and Stephenson-Moe, Christoph A and Vargas, Ian A and Meng, Zhuo and Thompson, Anthony J and Melchor, Julian and Wojtas, Caroline N and Rosario, Manuel A and Baker, Joel F and Deevers, Alexander C and Mouratidis, Roxann W and Sweeney, Michael J},
  title = {Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3617},
  doi = {10.3390/nu16213617}
}
Kostenlos starten →